The Manoach Lab at Massachusetts General Hospital is conducting a research study to explore brain activity during sleep and sensory processing in individuals living with Fragile X syndrome (FXS).
About the Study
Who can participate?
Males living with FXS between the ages of 12-19 years may be eligible to participate.
What will happen in the study?
If the individual qualifies and decides to be in this research study, they will come to the Lurie Center for Autism in Lexington, MA for 1-2 visits over 1-3 weeks. There is also a fully remote version of this study available for families who cannot travel to MA.
The following is a list of some of the activities that will happen during the study:
- (If needed) 1-2 weeks of practice with the sleep headband at home
- Wearing a sleep headband for 3 consecutive nights at home to monitor brain activity during sleep
- Completing assessments and questionnaires with the study staff
- (Optional) Wearing an EEG cap to monitor brain activity while listening to tones and clicks
What are the good things that can happen from this research?
This study will help researchers understand the brain basis of disrupted sleep in Fragile X syndrome so that it can be more effectively treated.
What are the bad things that can happen from this research?
The main risks of being in the study are discomfort from the sleep headband and worse sleep than usual. There may be other risks that we do not know about yet.
Will I or my child be paid to complete this study?
Participants receive up to $350 for participating in this study. Travel reimbursement up to $20 is available for eligible families.
Interested in Participating?
Our Most Recent Opportunities
Study: Identifying Translational Sleep Biomarkers in Autism
The Manoach Lab at Massachusetts General Hospital is conducting a research study to explore brain activity during sleep and sensory processing in individuals living with Fragile X syndrome (FXS).
Single-Dose Study for Adult Men with FXS
Cincinnati Children's Hospital Medical Center is looking for males ages 18-40 with FXS to participate in a single-dose clinical trial that is studying a drug called Gaboxadol.
Study: Somatic symptom development in 6-12 year old females with an FMR1 mutation (SoS Study)
Researchers at the New York State Institute for Basic Research are conducting a study to better understand the development of physical (somatic) symptoms in females living with and without an FMR1 gene variation.
Study: Web Intervention for Parents of Youth with Genetic Syndromes (WINGS)
Researchers at the Autism Assessment, Research, Treatment & Services (AARTS) Center at Rush University Medical Center are currently conducting a fully-virtual research study that is testing two telehealth interventions that are designed to help parents of children with genetic syndromes and intellectual disabilities gain strategies to manage challenging behaviors.
Neural Underpinnings of the Relationship Between Cognition and Gait Dysfunction in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
Movement disorders researchers at Rush University Medical Center are conducting a research study to learn about brain activation in people living with FXTAS during tasks like walking and thinking. This study is currently recruiting adults ages 50+ who are living with FXTAS.
Pharmacogenomics and the Fragile X Community: Interest and Prior Understanding
Researchers at the University of Alabama are looking for members of the FX community to take their online survey so they can explore the knowledge & opinions of the FXS community on pharmacogenomic testing.